← Latest news 
Bristol Myers CEO says India’s pharma talent is unmatched and AI will reshape medicines fast
Published on 24 April 2026
AI is set to transform how medicines get made
Bristol Myers Squibb CEO Chris Boerner tells ET Prime that India’s pharma talent pool is exceptionally strong. He also highlights the company’s push to become one of the fastest-growing firms by decade’s end, with AI playing a key role. Boerner says the approach could lead to truly transformational medicines while the company expands its footprint in India.
- Bristol Myers targets rapid growth by the end of the decade
- CEO credits India’s deep pharma talent pool
- AI is central to creating transformational medicines
- Company presence in India is expected to keep expanding
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times